Navigation Links
Diabetes Care Devices Market In Brazil, Russia, India, China (BRIC) Worth $570.56 Million In 2014
Date:6/15/2010

DALLAS, Texas, June 15, 2010 /PRNewswire/ -- According to the new market research report, "Diabetes care devices market in Brazil, Russia, India, China (BRIC)" published by MarketsandMarkets (http://www.marketsandmarkets.com), the diabetes care devices market in BRIC was approximately $257.55 million in 2009 and is expected to reach $570.56 million in 2014 at an estimated CAGR of 17.24% from 2009 to 2014.

Browse in-depth TOC on Diabetes Care Devices Market. Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/diabetes-care-devices-230. html

The report categorizes the overall BRIC market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems. The overall market is witnessing significant growth due to the increasing incidence of diabetes and the corresponding rise in governmental support for diabetes care across BRIC nations.

SCOPE AND FORMAT

The report analyzes the diabetes care devices market in Brazil, Russia, India, China on following parameters:

    - Which are the high growth segments in the diabetes care
      devices markets of Brazil, Russia, India, and China?
    - What are market estimates and forecasts; which are markets are
      doing well and which are not?
    - What is the competitive outlook; who are the main players in each
      segment; what are the key-selling products; what are their strategic
      directives, operational strength and product pipelines? Who is doing
      what?

    Related Reports

    - BRIC In-Vitro Diagnostics (IVD) Market in Brazil, Russia,
      India, China (2010 - 2014) (http://www.marketsandmarkets.com/Market-
      Reports/ivd-bric-market-198.html)
    - Medical Imaging - Global Displays and Post-Processing Software
      Market (2009 -2014) (
      http://www.marketsandmarkets.com/Market-Reports/medical-displays-
      179.html)
    - Microscopy - Advanced Technologies in Latin America (2009 - 2014)
      (http://www.marketsandmarkets.com/Market-Reports/Microscopy-Latin-
      America-238.html)
    - Global Dental Implants Market (
      http://www.marketsandmarkets.com/Market-Reports/Dental-Implants-Market-
      241.html)

(Due to the length of the above URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    http://www.marketsandmarkets.com


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes
2. Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism
3. Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
4. ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation
5. NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerance
6. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
7. Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
8. Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board
9. Array BioPharma and Amgen Partner in Type 2 Diabetes
10. Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting
11. BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... ... , ... Avomeen & MichBio will be hosting a BioMixer next week Thursday, ... Services (4840 Venture Dr., Ann Arbor, Michigan 48108). BioMixers are a casual, members-only ... with peers, make new connections and talk bio biz. , Cost:, ...
(Date:2/16/2017)... DUBLIN , Feb. 16, 2017 ... the "Synthetic Biology: Global Markets" report to ... ... synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis ... DNA synthesis and assembly, genome editing, bioinformatics and specialty ...
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 /PRNewswire/ ... their $7M Series B financing, adding an additional $3M ... led by Mesa Verde Venture Partners and other strategic ... be directed towards further accelerating commercial adoption of their ... profiling test and expanding the Paradigm cancer registry. ...
Breaking Biology Technology:
(Date:1/19/2017)... SANTA CLARA, Calif. , Jan. 19, 2017 ... Valley company enhancing user experience and security for ... provider of next-generation payment processing systems and cybersecurity ... assist more banks, enterprises and financial institutions worldwide ... As part of the end-to-end secure user authentication ...
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
Breaking Biology News(10 mins):